Apply through NovoCare
A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society explicitly states that restrictive eating disorder is a general contraindication to GLP-1 use and that individuals with a history of eating disorders should be referred to an eating disorders specialist before these medications are prescribed ( Mozaffarian et al., Am J Clinical Nutrition, 2025 )
For those in a maintenance phase after weight loss, microdosing can help preserve metabolic gains without the appetite suppression of higher doses, prioritizing sustainability , tolerability , and resilience important for long-term health optimization
H.ZhaoX
When taking semaglutide for weight loss, you can expect to see changes very soon
The GLP-1 antagonist, exendin 939, regulates nociception via TRPV1 modulation Exendin 939, a synthetic peptide, functions as a specific and competitive antagonist of GLP-1 38